Overview
- 8 inspections across 8 sites are on record.
- 47 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-01-17.
At a glance
Inspections
8
Sites
8
Observations
47
Career since
Sep 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Intarcia Therapeutics, Inc. | 17 Jan 2020 | Human Drugs | View 483 → |
| Catalent Pharma Solutions, LLC | 21 Dec 2018 | Human Drugs | View 483 → |
| Lonza Bend Inc. | 27 Jul 2018 | Human Drugs | On file |
| Actavis Laboratories FL, Inc. | 19 Jul 2018 | Human Drugs | View 483 → |
| Aeropharm Gmbh | 8 Nov 2017 | Human Drugs |
Sites inspected
Intarcia Therapeutics, Inc.Hayward, United States1 insp.
Catalent Pharma Solutions, LLCWinchester, United States1 insp.
Lonza Bend Inc.Bend, United States1 insp.
Actavis Laboratories FL, Inc.Davie, United States1 insp.
Aeropharm GmbhRudolstadt, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
William J Leonard2 shared
Arie Menachem2 shared
Kouros Kangarli1 shared
Jeffrey P Raimondi1 shared
Uttaniti Limchumroon1 shared
Fabian N Chaparro-Rodriguez1 shared
Ileana Barreto-Pettit1 shared
Wayne D Mcgrath1 shared
Andrew J Barrowcliff1 shared
Jennifer L Huntington1 shared
Full investigator report
Get the verbatim findings behind Chiaochun J Wang's 47 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site